Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1976-12-1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0026-556X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
601-7
|
pubmed:dateRevised |
2009-10-27
|
pubmed:meshHeading |
pubmed-meshheading:967133-Angina Pectoris,
pubmed-meshheading:967133-Cardiac Volume,
pubmed-meshheading:967133-Coronary Circulation,
pubmed-meshheading:967133-Dose-Response Relationship, Drug,
pubmed-meshheading:967133-Drug Therapy, Combination,
pubmed-meshheading:967133-Humans,
pubmed-meshheading:967133-Propranolol
|
pubmed:year |
1976
|
pubmed:articleTitle |
Role and rationale of the use of propranolol in the treatment of patients with angina pectoris.
|
pubmed:publicationType |
Journal Article
|